Cargando…

Oxygen dependence for chemosensitization by misonidazole.

Misonidazole (MISO) potentiates the cell killing effect of certain chemotherapy agents, but only under hypoxic conditions. The purpose of the present study was to define the range of oxygen concentrations over which chemosensitization by MISO takes place using mammalian cells cultured in vitro, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roizin-Towle, L., Hall, E. J., Pirro, J. P.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1986
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001598/ https://www.ncbi.nlm.nih.gov/pubmed/3801287

Ejemplares similares

Studies with bleomycin and misonidazole on aerated and hypoxic cells.
por: Roizin-Towle, L., et al.
Publicado: (1978)

Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
por: Roizin-Towle, L. A., et al.
Publicado: (1981)

Factors influencing the chemosensitization of melphalan by misonidazole.
por: Randhawa, V. S., et al.
Publicado: (1985)

Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
por: Durand, R. E., et al.
Publicado: (1987)

An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
por: Twentyman, P. R., et al.
Publicado: (1983)

Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
por: Lee, F. Y., et al.
Publicado: (1983)

Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
por: Lee, F. Y., et al.
Publicado: (1984)

Studies with cis-diamminedichloro-platinum II and exogenous polyamines using mammalian cells in culture.
por: Roizin-Towle, L.
Publicado: (1981)

In vitro metabolism of misonidazole.
por: Josephy, P. D., et al.
Publicado: (1981)

Dependence of misonidazole binding on factors associated with hypoxic metabolism.
por: Ling, L. L., et al.
Publicado: (1987)

Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.
por: Miller, R. C., et al.
Publicado: (1978)

Bleomycin and misonidazole cytotoxicity.
por: Korbelik, M., et al.
Publicado: (1985)

Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
por: Taylor, Y. C., et al.
Publicado: (1980)

Microscopic distribution of misonidazole in mouse tissues.
por: Cobb, L. M., et al.
Publicado: (1989)

Optimizing the interval between administration of misonidazole and irradiation: an in vitro study.
por: Hall, E. J., et al.
Publicado: (1982)

Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
por: Astor, M., et al.
Publicado: (1979)

The penetration of misonidazole into spontaneous canine tumours.
por: White, R. A., et al.
Publicado: (1979)

Split dose cytotoxic experiments with misonidazole.
por: Stratford, I. J.
Publicado: (1978)

Chemopotentiation of CCNU metabolites by misonidazole.
por: Mulcahy, R. T.
Publicado: (1985)

Peripheral electrophysiological parameters in mice treated with misonidazole.
por: Von Burg, R., et al.
Publicado: (1979)

The penetration of misonidazole into a mature structural cartilage.
por: Langler, A. J., et al.
Publicado: (1982)

The role of dexamethasone in the modification of misonidazole pharmacokinetics.
por: Jones, D. H., et al.
Publicado: (1983)

Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
por: Honess, D. J., et al.
Publicado: (1980)

Effect of misonidazole on radiation injury to mouse spinal cord.
por: Travis, E. L., et al.
Publicado: (1982)

Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
por: Hirst, D. G., et al.
Publicado: (1982)

The quantitative response of human tumours to radiation and misonidazole.
por: Ash, D. V., et al.
Publicado: (1979)

Modulation of the hypoxic toxicity and binding of misonidazole by glucose.
por: Ling, L. L., et al.
Publicado: (1986)

Interactions between misonidazole and hyperthermia in EMT6 spheroids.
por: Morgan, J. E., et al.
Publicado: (1981)

Is tumour radiosensitization by misonidazole a general phenomenon?
por: Denekamp, J., et al.
Publicado: (1980)

Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse.
por: Clarke, C., et al.
Publicado: (1982)

Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
por: Moore, J. L., et al.
Publicado: (1981)

Influence of the hypoxic cell sensitizer misonidazole on the proliferation of well-oxygenated cells in vitro during prolonged exposure.
por: Deys, B. F., et al.
Publicado: (1979)

Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
por: Wheeler, K. T., et al.
Publicado: (1984)

The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.
por: Murray, J. C., et al.
Publicado: (1987)

Effect of local hyperthermia on the acute toxicity of misonidazole in mice.
por: Overgaard, J.
Publicado: (1979)

A biochemical method for assessing the neurotoxic effects of misonidazole in the rat.
por: Rose, G. P., et al.
Publicado: (1980)

Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
por: Law, M. P., et al.
Publicado: (1981)

In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
por: Siemann, D. W.
Publicado: (1981)

Distribution of misonidazole in human tumours and normal tissues.
por: Ash, D. V., et al.
Publicado: (1979)

Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans.
por: McDermott, B. J., et al.
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_399o1gmqn6vj9i3tk8c5aro6ae